VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $36,201,000 | -28.6% | 1,622,648 | -29.7% | 0.16% | -29.9% |
| Q1 2018 | $50,721,000 | +546.9% | 2,307,587 | +583.9% | 0.22% | +497.3% |
| Q4 2017 | $7,841,000 | +450.6% | 337,400 | +444.2% | 0.04% | +428.6% |
| Q3 2017 | $1,424,000 | +4.0% | 62,000 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $1,369,000 | -58.6% | 62,000 | -57.2% | 0.01% | -70.4% |
| Q1 2017 | $3,305,000 | -59.1% | 144,941 | -62.5% | 0.03% | -52.6% |
| Q4 2016 | $8,082,000 | -75.5% | 386,302 | -69.1% | 0.06% | -76.7% |
| Q3 2016 | $32,998,000 | +188.7% | 1,248,545 | +202.7% | 0.24% | +175.3% |
| Q2 2016 | $11,430,000 | – | 412,491 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |